Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR ASAP prehospital nitroglycerin patch trial for acute stroke
NL-OMON47827Phase 3Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nitroglycerin in stroke, ischemic stroke and intracerebral hemorrhage (ICH) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Functional outcome at 90 days. Started Apr 2018; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
strokeischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON47827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47827.